Minimizing Disability from Graft-Versus-Host Disease

被引:0
|
作者
Andrews C.C. [1 ]
机构
[1] Department of Physical Medicine and Rehabilitation, University of Michigan, 325 E. Eisenhower Pkwy, Ann Arbor, 48108, MI
关键词
Avascular necrosis; Cancer rehabilitation; Chronic graft-versus-host disease; Fascial GVHD; Steroid myopathy;
D O I
10.1007/s40141-018-0189-6
中图分类号
学科分类号
摘要
Purpose of Review: Graft-versus-host disease (GVHD) is a complication of hematopoietic stem cell transplantation which can result in significant disability. Any organ system may be affected, and as a result, a wide variety of functional impairments may occur. Rehabiliation services can improve patient outcomes and quality of life, but an understanding of the underlying disease process is necessary. Recent Findings: There have been few studies published recently regarding the management of functional impairments in GVHD patients. The National Institutes of Health Consensus Development Project on Criteria in Chronic Graft-versus-Host Disease is an ongoing project begun in 2005 and most recently updated in 2014; however, these data have not yet been used to assess the management of disability in this population. Summary: The treatment of functional impairments from GVHD remains largely annectdotal and based around experiences from similar diseases; however, rehabilitation interventions should still be considered for patients with significant disease burden. © 2018, Springer Science+Business Media, LLC, part of Springer Nature.
引用
收藏
页码:131 / 135
页数:4
相关论文
共 50 条
  • [1] Disability Related to Chronic Graft-versus-Host Disease
    Hamilton, Betty K.
    Storer, Barry E.
    Wood, William A.
    Pidala, Joseph A.
    Cutler, Corey S.
    Martin, Paul J.
    Chen, George
    Flowers, Mary E.
    Lee, Stephanie J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (04) : 772 - 777
  • [2] GRAFT-VERSUS-HOST DISEASE OR GRAFT-VERSUS-HOST LIKE SYNDROME
    BEYER, J
    SCHWERDTFEGER, R
    SIEGERT, W
    BLOOD, 1992, 80 (11) : 2948 - 2949
  • [3] GRAFT-VERSUS-HOST DISEASE
    SVEDENTSOV, YP
    SHARYGIN, SL
    EPIFANOV, NS
    MATVEEV, GA
    KLINICHESKAYA MEDITSINA, 1993, 71 (05): : 19 - 23
  • [4] Graft-versus-Host Disease
    Choi, S.
    Reddy, P.
    PANMINERVA MEDICA, 2010, 52 (02) : 111 - 124
  • [5] GRAFT-VERSUS-HOST DISEASE
    DEEG, HJ
    TRANSFUSION SCIENCE, 1994, 15 (03): : 187 - 188
  • [6] GRAFT-VERSUS-HOST DISEASE
    VOGELSANG, GB
    WAGNER, JE
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1990, 4 (03) : 625 - 639
  • [7] GRAFT-VERSUS-HOST DISEASE OR GRAFT-VERSUS-HOST LIKE SYNDROME - RESPONSE
    YEAGER, AM
    BLOOD, 1992, 80 (11) : 2949 - 2950
  • [8] GRAFT-VERSUS-HOST DISEASE
    KODO, H
    ACTA HAEMATOLOGICA JAPONICA, 1987, 50 (08): : 1621 - 1626
  • [9] Graft-versus-host disease
    Moreno, David F.
    Cid, Joan
    MEDICINA CLINICA, 2019, 152 (01): : 22 - 28
  • [10] Graft-versus-host disease
    Warren D. Shlomchik
    Nature Reviews Immunology, 2007, 7 : 340 - 352